Biogen Inc (NASDAQ:BIIB)

271.23
Delayed Data
As of 4:26pm ET
 +1.29 / +0.48%
Today’s Change
223.25
Today|||52-Week Range
468.55
+10.77%
Year-to-Date
The Zacks Analyst Blog Highlights: Salesforce, AT&T, Boeing, Biogen and Arthur J. Gallagher & Co
7:12am / Zacks.com - Paid Partner Content
Biogen Inc. (BIIB) Q3 Earnings and Revenues Surpass Estimates
Oct 20 / Zacks.com - Paid Partner Content
Was Atea Pharmaceutical's Flop Predictable?
6:45am / MotleyFool.com - Paid Partner Content
2 Stocks That Could Grow Your Portfolio Over the Next Decade
Oct 20 / MotleyFool.com - Paid Partner Content
Top Research Reports for salesforce, AT&T & Boeing
Oct 25 / Zacks.com - Paid Partner Content
3 Biotech Stocks That Are Ridiculously Overpriced
Oct 20 / MotleyFool.com - Paid Partner Content
3 Bargain Stocks to Buy and Hold Long Term
Oct 25 / StockNews.com - Paid Partner Content
This is the secret to dealing with inflation
Oct 20 / CNN.com - Paid Partner Content
There's Money to Be Made With Vertex, Viatris, Incyte and Biogen
Oct 24 / GuruFocus News - Paid Partner Content
Biogen (BIIB) to Report Q3 Earnings: What's in the Cards?
Oct 18 / Zacks.com - Paid Partner Content
3 Big Problems With Biogen's Q3 Results
Oct 23 / MotleyFool.com - Paid Partner Content
Biogen's (BIIB) Tofersen Reports Mixed Data From ALS Study
Oct 18 / Zacks.com - Paid Partner Content
Why Ionis Pharmaceuticals Stock Is Down 13% This Week
Oct 22 / MotleyFool.com - Paid Partner Content
2 Top Healthcare Stocks That Could Be Bought Out in 2022
Oct 16 / MotleyFool.com - Paid Partner Content
Biogen inc (BIIB) Q3 2021 Earnings Call Transcript
Oct 20 / MotleyFool.com - Paid Partner Content
Prothena (PRTA) Riding High on Alzheimer's Disease Pipeline
Oct 15 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: BIIB's Q3 Earnings, REGN's COVID-19 Cocktail Update & More
Oct 20 / Zacks.com - Paid Partner Content
3 Highly Profitable Stocks Wall Street Thinks Will Soar 39% or More
Oct 15 / MotleyFool.com - Paid Partner Content
Sage, Biogen Plan to File Zuranolone NDA for MDD in 2022
Oct 20 / Zacks.com - Paid Partner Content
Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for
Oct 13 / Zacks.com - Paid Partner Content
Biogen (BIIB) Q3 Earnings Top, Aduhelm Sales Negligible
Oct 20 / Zacks.com - Paid Partner Content
3 Top Healthcare Stocks That Could Rise More Than 40% in 12 Months
Oct 13 / MotleyFool.com - Paid Partner Content